RTW Investments’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-821,288
Closed -$17.6M – 78
2022
Q4
$17.6M Sell
821,288
-2,803,712
-77% -$59.8M 0.36% 39
2022
Q3
$65M Buy
+3,625,000
New +$47.6M 1.5% 22
2022
Q1
– Sell
-6,722,624
Closed -$112M – 125
2021
Q4
$112M Hold
6,722,624
– – 1.64% 20
2021
Q3
$109M Hold
6,722,624
– – 1.65% 20
2021
Q2
$42.4M Hold
6,722,624
– – 0.64% 42
2021
Q1
$41.5M Hold
6,722,624
– – 0.65% 44
2020
Q4
$46.5M Buy
6,722,624
+59,185
+0.9% +$379K 0.78% 36
2020
Q3
$37.6M Buy
6,663,439
+66,903
+1% +$319K 0.9% 34
2020
Q2
$33.6M Buy
+6,596,536
New +$27.5M 0.95% 33

Other funds holding ISEE

RTW Investments's ISEE Position: Q1 2023 in Review

RTW Investments sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q1 2023, closing a stake of 821,288 shares — an estimated $17.6M sold.

RTW Investments first reported a position in ISEE in Q2 2020 and held it in 9 quarters. The position peaked at $112M in Q4 2021. 223 funds tracked by Wall St. Rank hold ISEE as of Q1 2023.

  • RTW Investments reported no remaining IVERIC bio, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • RTW Investments sold 821,288 IVERIC bio, Inc. Common Stock shares in Q1 2023, an estimated $17.6M.
  • RTW Investments first reported a position in IVERIC bio, Inc. Common Stock in Q2 2020 and held it in 9 quarters.
  • RTW Investments's IVERIC bio, Inc. Common Stock position peaked at $112M in Q4 2021.
  • 223 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q1 2023.

Based on RTW Investments's 13F filing for Q1 2023, filed 15 May 2023.